PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 283 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Antibody-drug conjugates: Why it takes a village to make them

Chemical & Engineering NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Difficult to digest top hotel brands failing the sniff test

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends licences of 12 Pune, Sangli outlets

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

More than $1M in funding at UH College of Pharmacy to solve complex health challenges

EurekAlert!Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra: Ayurvedic drug makers under FDA radar

RediffOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech news from around the world

NatureOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Commercialising drugs in Europe: Lean models for first-time launchers

Pharmaceutical TechnologyOriginal source
🇨🇦Researchwomenscollegehospital.caTier 2 · Direct publisher

Introducing the Menopause Empowerment Project: Helping people navigate menopause with confidence

Women's College HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Pharmaceutical Industry’s Track-and-Trace Test

ismworldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report

pharmexec.comOriginal source
🇨🇦Researchnews.ubc.caTier 2 · Direct publisher

Construction underway on new location for UBC Learning Exchange

University of British ColumbiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sentynl gains US rights to Mereo's Phase III alvelestat for alpha-1 lung disease

AllSciOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opinion: San Diego biotechs in holding pattern over NIH funding freeze

Times of San DiegoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

German biotech company targets sea lice via aquafeed treatment

Global Seafood AllianceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medic

The Times of IndiaOriginal source
🌍Regulatoryinfarma.plTier 1 · Regulatory source

Dobre prawo wymaga dialogu, nie etykiet

INFARMA PolandOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

'Unhygienic Premises, No Testing': Maharashtra FDA Cracks Down On Ayurvedic Drug Makers

Asianet NewsableOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Latham Steers Biotech Co. Novonesis' Australian Biz Takeover

Law360Original source
🌍discoverynews.google.comTier 3 · Aggregated media

The State of Biotech 2026

Genetic Engineering and Biotechnology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Future of Self-Affirmed GRAS: Balancing Innovation, Transparency, and Food Safety

Food Safety MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Belenos Biosciences Announces Positive Topline Results from a Phase 2 Clinical Trial of BEL512 in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Business WireOriginal source
🇺🇸Industrytechcyte.comTier 1 · Company source

Techcyte and Conflux Bring Transformative AI-Native Reporting to the Digital Pathology Workflow

TechcyteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ:LEGN) Announces Earnings Results

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HHT Patients Get First Phase 3 Drug Trial After 130 Years Without Treatment

Tech TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Alterity Therapeutics (ATHE) Rated Buy by Craig-Hallum Amid Phase 3 Trial Optimism

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does TrumpRx's Price Talk Match Patient Savings?

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Shrooms, Inc.: Why CMPS Could Be 2027’s Wildest Biotech Bet

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

WIU Alumna Recognized as Subject Matter Expert by International Society For Pharmaceutical Engineering

Western Illinois UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

$2bn+ BMS Pharmaceutical Manufacturing Campus Slated for Generation Park, Houston

Construction ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Playbook Breakdown: Who Will Risk Developing Tomorrow's Cures?

Life Science LeaderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ:LEGN) Shares Gap Up After Strong Earnings

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech shares rise 5% as Q2 earnings and revenue beat estimates

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Voyageur Pharmaceuticals Advances Bayer Collaboration and Critical Minerals in the American Pharmaceutical Industry

InvestorNewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Zydus’ Sentynl pens $475M deal for Mereo rare lung disease drug

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EXCLUSIVE: The journey to create Staubli's new robot for pharmaceutical manufacturing

Cleanroom TechnologyOriginal source
🌍Industryeikontx.comTier 1 · Company source

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Eikon TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Chasing Dupixent, a biotech aims to make better antibody drugs for eczema

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ATAI Beckley earnings on deck as investors eye Lilly deal By Investing.com

Investing.com IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA crackdown on Ayurvedic drug makers: 10 manufacturers in Maharashtra lose licences permanently

mid-day.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ATAI Beckley earnings on deck as investors eye Lilly deal By Investing.com

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Soter Bio Ends Lobbying Relationship With Tenagrity Solutions

Legis1Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Q2 2026 slides: first profitable quarter, 50% growth

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Critical Layer for Pharma's Growing Direct-to-Patient Play

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI diagnostics and biotech reshape the future of personalized beauty, says Revieve

Personal Care InsightsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Q2 Earnings Call Highlights

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cambrex Invests $30 Million in Milan R&D and Manufacturing Expansion

citybizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Q2 Earnings Call Highlights

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Biotech Growth Trust PLC - Net Asset Value(s)

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: Legend Biotech tops Q2 2026 estimates as stock rises 5%

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Campbell unites pharmaceutical science, clinical research in future-focused degree

Campbell University NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Luxembourg’s space BioTech Exobiosphere secures €1 million to find “cures from space”

EU-StartupsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CSPC Pharmaceutical Initiates Phase I Trial Of SYS6063 For Relapsed, Refractory SLE In China

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Introducing Veritas24-7™ - A New Way for Pharmaceutical Companies to Engage Physicians 24 Hours a Day

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Intelligent Bio Solutions' Fingerprint Drug Study Enrolled 135

Stock TitanOriginal source
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Proteine: quante ne servono al giorno

Humanitas Research HospitalOriginal source